Zimbabwe’s new Global Fund grants for TB/HIV are clearly aligned to the country’s epi profile and its national strategic plans, TRP says
In their recommendation to the Board on Zimbabwe’s TB/HIV funding request, the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC) commented favorably on Zimbabwe’s inclusion of interventions to address barriers related to human rights and gender, and its focus on key populations for HIV, TB and STI care and treatment.
As GFO reported a few weeks ago, Zimbabwe submitted a TB/HIV funding request for $629 million in Window 1 of the current funding cycle. The $629 million request consisted of $432 million that was within Zimbabwe’s allocation, and $197 million for a prioritized above-allocation request (PAAR).
On 20 March 2017, Zimbabwe submitted a TB/HIV funding request to the Global Fund for $628.9 million. This includes an allocation request for $431.9 million and a prioritized above allocation request (PAAR) of $197 million. A separate funding request for malaria was submitted on the same day for $51.7 million.
An Office of the Inspector General investigation report on the awarding of contracts to the Mutambara Foundation in Zimbabwe reveals fraudulent activity
In November 2015, the Fund’s Sourcing Department (which is responsible for procurements carried out by the Global Fund Secretariat for its operational expenses), alerted the Office of the Inspector General (OIG) to an anonymous email that alleged professional wrongdoing on the part of the Director of the Mutambara Foundation in Zimbabwe.
Since entering the New Funding Model (NFM) as an early applicant in 2013, Zimbabwe has been a unique case for Global Fund investments. The country submitted a single HIV concept note in April 2013 (before integrated HIV/TB concept notes were encouraged), was granted $311.2 million, and began implementation in January 2014.
Zimbabwe received a mixed report card in an audit performed by the Office of the Inspector General. The OIG rated internal controls and grant implementation arrangements as effective, but said that improvements were needed in supply chain management and the quality of services provided. A report on the audit was released on 13 July.
Elimination 8 (E8) has set the formidable target of full malaria elimination in Botswana, Namibia, South Africa and Swaziland by 2020. Termed the “frontline four”, these countries are nearing elimination of the disease after achieving a 75% decline between 2000 and 2012.
New funding model early applicant Zimbabwe submitted a $40.2 million request for incentive funding on 18 May, seeking additional financial support for interventions that specifically target people under age 24: the fastest growing demographic group in sub-Saharan Africa for new HIV infections.
A ministerial-level meeting took place on 25 March in South Africa, aiming to harmonize tracking, tracing, diagnosis and referrals for people affiliated with southern Africa's lucrative mining sector -- all of whom are at high risk for contracting tuberculosis.